Cure My Disease

Don't miss your cure!

 Log in / Sign up

New surgery aims to fix pelvic organ prolapse with fewer complications

NCT ID NCT07271862

Disease control Sponsor: Riga East Clinical University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, simpler laparoscopic surgery for women with pelvic organ prolapse (when pelvic organs drop from their normal position). The goal is to restore anatomy and improve quality of life while reducing risks from surgical mesh. The study involves 60 women aged 30-80 who have not had prior prolapse surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Aug 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 80 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Female patients with symptomatic isolated or combined forms of pelvic organ prolapse, corresponding to stage II-IV according to the POP-Q classification. 2. Age between 30 and 80 years. 3. Presence or absence of urinary incontinence symptoms. 4. Preoperatively verified by urodynamics: occult, mild, or severe stress urinary incontinence, or absence thereof. 5. Presence or absence of proctogenic constipation. 6. No prior surgical interventions for pelvic organ prolapse or urinary incontinence. 7. History of supracervical hysterectomy. Exclusion Criteria: 1. Severe extragenital pathology contraindicating surgical treatment. 2. Malignant pelvic pathology. 3. Asymptomatic patients. 4. Patient refusal to undergo subtotal hysterectomy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female sexual dysfunction (FSD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female stress incontinence pelvic organ prolapse physiological sexual disorder Urinary Incontinence Urinary Incontinence, Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Female sexual dysfunction (FSD) Pelvic organ prolapse (POP) Quality of life Urinary incontinence (UI) Urinary incontinence,stress

Contacts and locations

Locations

  • Riga East Clinical University Hospital. Pauls Stradins Clinical University Hospital.

    Riga, Latvia

More trials for these conditions

Other studies related to the condition(s) this trial covers.